Antivenom Market – Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Global Antivenom Market: by product type (Monovalent, Polyvalent), by Animal (Snake, Scorpions, Spiders, Others), by Distribution channel (Hospital Pharmacies, Retail Pharmacies, Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: , Tag:

Report

Description

Antivenom Market size valued at USD 1000 million in 2021 and expected to reach USD 1747.4 million by 2028, at a CAGR of 8.3% during the forecast period 2022 to 2028. Antivenom is also called as antivenin. Antivenom is a medication prepared from antibodies which are used to treat certain venomous bites. Poisonous bites result in certain clinical conditions such as muscle weakness, secretion of excessive saliva, breathing problems, along with other difficulties, in some instance that might lead to death as well. Antivenins are recommended only if there is significant toxicity or high risk of toxicity. Antivenom is made by collecting venom from the relevant venomous species of spider, snake, fish, injecting venom in little amounts to domestic animals and antibodies are separated from blood purification. These antibodies are used as antivenom. Growing demand of antivenom worldwide, especially in Africa and Asia-Pacific region owing to more number of venomous bite incidents. According to World Health Organization (WHO), about 5 Mn snake bites occur each year, resulting 2.5 Mn envenomings (poisoning because of snake bites), minimum 100,000 deaths and around three times as many amputations and other permanent disabilities. Withdrawal of antivenoms like Fav-Afrique by Pfizer further grew demand for the market. Market players are also actively involving in R&D to develop antivenoms and to enhance their market position. In addition, many market players and institutions are actively involved in the development of new antivenoms. For instance, Equine F (ab’) 2 in antivenin is being developed by Instituto Bioclon S.A (clinical trials phase 2) for treatment of poisoning by scorpion sting. Based on the aforementioned factors market is expected to grow with significant CAGR rate during the forecast period. Polyvalent anti-venoms are antibodies that can neutralise a variety of homologous venoms from different species/genera. In most circumstances and roughly 80% of the time when a monovalent antivenom cannot be chosen, polyvalent antivenoms can save the lives of snake envenomation victims, even when the perpetrator snake is unknown. Polyvalent anti-venoms are the most recommended anti-venom medication due to their evident advantages. Because of the current COVID-19 situation, all firms’ research and development resources are being diverted to COVID-19 research, and there has been little or no research in this category in recent years, which will have an impact on market growth.

Antivenom Market

MARKET SUMMARY
-
8.3% CAGR
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 8.3%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Antivenom Market

  • The report on global Antivenom Market gives historical, current, and future market sizes (US$ Mn) on the basis of manufacturing process, type of product type, animal, distribution channel and geography.
  • Antivenom Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa
Key Players
  • Vins Bioproducts Limited (India)
  • Bharat Serum and Vaccines Limited (India)
  • CSL Limited (Victoria), Rare Disease Therapeutics, Inc. (U.S.)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Instituto Bioclon, S.A. de C.V.(Mexico)
Dynamics

Antivenom Market

Increase in government initiatives to develop antivenoms and incidents of the venomous bites in undeveloped regions are fueling the growth of market over the forecast period. In addition, rise in deaths due to venomous bites and technological advancements in the development of antivenom creates significant opportunities for the antivenom manufacturers. However, complexity in regulatory procedures, insufficient funding in development of antivenom, and high cost of the product are hindering growth.


North-America got significant share

Antivenom Market

Geographically market is segmented into following regions viz. North America, Asia-Pacific, Latin America, Europe, and Middle East & Africa. North America contributes a major share in market due to the establishment of snake poison control centres, increase in antivenom products approval, rise in number of antivenom clinical trial conducting firms and presence of established health care facilities. Asia Pacific anti venom market is expected to have lucrative market growth owing to increase in number of snake bite cases as compared to developed regions. Furthermore, development of antivenom products for several species of snakes, rising demand for antivenom products, and increase in a number of local antivenom manufacturers such as Bharath Serum, Vaccines Limited and Vins Bioproducts focusing on antivenom products in the Asia region. In the case of the Middle East and Africa region, South Africa expected to have significant growth opportunity due to the highest number of snake bites in the country. Many of the global players are expected to expand their business to African market during the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share and forecast
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

Antivenom Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

  1. Executive summary
  2. Global Antivenom Market Introduction
    • Global Antivenom Market – Taxonomy
    • Global Antivenom Market–Definitions
      • Antivenom Type
      • Reptile Type
      • Immunoglobulin Type
      • Distribution Channel
      • Region
  1. Global Antivenom Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Antivenom Market Dynamics – Factors Impact Analysis
    • Global Antivenom Market Dynamics – Regulations
      • US
      • Europe
      • Japan
      • China
    • Global Antivenom Market– Product Innovations
  • Price Analysis
  • Technological Landscape
  • Value Chain Analysis
  • Competitor Landscape
  • Recent Flexible e-paper Product Launches
  • Funds raised by the Start-ups
  • Collaborations and acquisitions in market
  1. Global Antivenom Market Analysis 2017 – 2025
    • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  2. Global Antivenom Market, By Antivenom Type, 2018 – 2024
    • Monovalent
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Bivalent
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Trivalent
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Tetravalent
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Polyvalent
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
  1. Global Antivenom Market , By Reptile Type, 2018 – 2024
    • Snakes
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  1. 2.3. Market Opportunity Analysis
    • Scorpions
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Others
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
  1. 2.3. Market Opportunity Analysis
  2. Global Antivenom Market Forecast, By Immunoglobulin Type, 2018 – 2024
    • Homologous
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Heterologus
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
  1. Global Antivenom Market Forecast, By Distribution channel, 2018 – 2024
    • Hospital Pharmacies
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
  1. Global Antivenom Market Forecast, By Region, 2018 – 2024
    • North America
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Europe
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Middle East & Africa
      • Market Analysis and Forecast, 2017 – 2025 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis
      • Market Opportunity Analysis
    • Global Antivenom Market – Opportunity Analysis Index, By Antivenom Type,

Reptile  Type, Immunoglobulin  Type, Distribution Channel and Region, 2017 – 2025

  1. North America Antivenom Market Analysis 2018 – 2024
    • Antivenom Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y

Growth (%), and Market Share (%)

  • Monovalent
  • Bivalent
  • Trivalent
  • Tetravalent
  • Polyvalent
  • Reptile Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%),

and Market Share (%)

  • Snakes
  • Scorpions
  • Others
  • Immunoglobulin Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y

Growth (%), and Market Share (%)

  • Homologous
  • Heterologous

12.1.4.Distribution Channel Analysis Forecast (2017 – 2025) by Revenue (USD Mn),

Y-o-Y Growth (%), and Market Share (%)

12.1.4.1. Hospital Pharmacies

12.1.4.2. Retail Pharmacies

12.1.4.5. Others

12.1.5Country Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%),

and Market Share (%)

10.1.5.1. U.S

10.1.5.2. Canada

  • North America Antivenom Market – Opportunity Analysis Index, By Antivenom Type,

Reptile  Type, Immunoglobulin  Type, Distribution Channel, and Country, 2017 – 2025

  • North America Antivenom Market Dynamics – Trends

Europe Antivenom Market Analysis 2018 – 2024

11.1.1.Antivenom Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn),

Y-o-Y Growth (%), and Market Share (%)

  • Monovalent
  • Bivalent
  • Trivalent
  • Tetravalent
  • Polyvalent

11.1.2.Reptile  Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%),

and Market Share (%)

11.1.2 Snakes

11.1.2.1. Scorpions

11.1.2.2. Others

11.1.3.Immunoglobulin  Type Analysis Forecast (2017 – 2025) by Revenue (USD Mn),

-o-Y Growth (%), and Market Share (%)

11.1.3.1. Homologous

11.1.3.2. Heterologus

11.1.4.Distribution Channel Analysis Forecast (2017 – 2025) by Revenue


Report

Company Profile

  • Vins Bioproducts Limited (India)
  • Bharat Serum and Vaccines Limited (India)
  • CSL Limited (Victoria), Rare Disease Therapeutics, Inc. (U.S.)
  • F. Hoffmann-La Roche AG (Switzerland)
  • Instituto Bioclon, S.A. de C.V.(Mexico)
  • Incepta Vaccine Ltd. (Bangladesh)
  • BTG Plc (U.K)
  • Merck & Co., Inc. (U.S)
  • Pfizer Inc. (U.S.)

Description

Antivenom Market size valued at USD 1000 million in 2021 and expected to reach USD 1747.4 million by 2028, at a CAGR of 8.3% during the forecast period 2022 to 2028. Antivenom is also called as antivenin. Antivenom is a medication prepared from antibodies which are used to treat certain venomous bites. Poisonous bites result in certain clinical conditions such as muscle weakness, secretion of excessive saliva, breathing problems, along with other difficulties, in some instance that might lead to death as well. Antivenins are recommended only if there is significant toxicity or high risk of toxicity. Antivenom is made by collecting venom from the relevant venomous species of spider, snake, fish, injecting venom in little amounts to domestic animals and antibodies are separated from blood purification. These antibodies are used as antivenom. Growing demand of antivenom worldwide, especially in Africa and Asia-Pacific region owing to more number of venomous bite incidents. According to World Health Organization (WHO), about 5 Mn snake bites occur each year, resulting 2.5 Mn envenomings (poisoning because of snake bites), minimum 100,000 deaths and around three times as many amputations and other permanent disabilities. Withdrawal of antivenoms like Fav-Afrique by Pfizer further grew demand for the market. Market players are also actively involving in R&D to develop antivenoms and to enhance their market position. In addition, many market players and institutions are actively involved in the development of new antivenoms. For instance, Equine F (ab’) 2 in antivenin is being developed by Instituto Bioclon S.A (clinical trials phase 2) for treatment of poisoning by scorpion sting. Based on the aforementioned factors market is expected to grow with significant CAGR rate during the forecast period. Polyvalent anti-venoms are antibodies that can neutralise a variety of homologous venoms from different species/genera. In most circumstances and roughly 80% of the time when a monovalent antivenom cannot be chosen, polyvalent antivenoms can save the lives of snake envenomation victims, even when the perpetrator snake is unknown. Polyvalent anti-venoms are the most recommended anti-venom medication due to their evident advantages. Because of the current COVID-19 situation, all firms’ research and development resources are being diverted to COVID-19 research, and there has been little or no research in this category in recent years, which will have an impact on market growth.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX